{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T23:22:32Z","timestamp":1768000952379,"version":"3.49.0"},"reference-count":84,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T00:00:00Z","timestamp":1550707200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Australian National Health and Medical Research Council"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Health Science Reports"],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background and aims<\/jats:title><jats:p>The prevalence of chronic benzodiazepine use in primary care settings remains high despite clear evidence of adverse health outcomes resulting from long\u2010term use and the availability of effective alternative behavioural therapies. Eliciting factors influencing past or current usage experience of benzodiazepine users and their future behavioural intention regarding discontinuation or alternative behavioural therapy adoption could be useful in developing informed strategies facilitating successful benzodiazepine withdrawal in long\u2010term users. The aim of this study was to identify patient factors influencing their current long\u2010term benzodiazepine use, past withdrawal attempt, and future intention to trial safer alternative behavioural therapies. Additionally, the study also aimed to explore patients' preference for information sources on behavioural therapies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Point of purchase surveys were conducted with patients obtaining benzodiazepines from selected pharmacies across New South Wales (NSW), Australia. Survey items included the Beliefs about Medicines Questionnaire (BMQ\u2010specific), questions about patient's sociodemographic characteristics, as well as their views about long\u2010term benzodiazepine use and behavioural therapies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Seventy\u2010five patients were recruited from 12 pharmacies across New South Wales (NSW). The surveys were conducted from November 2016 to July 2017. The mean (\u00b1SD) age of the participants was 54.3 (\u00b116.7) with a range of 23 to 86\u00a0years, and 67% of the participants had been using the benzodiazepine for at least 1\u00a0year. Lower\u2010education levels, stronger beliefs about the necessity of use, and lower concerns about ongoing benzodiazepine use were significantly associated with prolonged use. Sixty\u2010four percent of the participants were not interested in behavioural therapies, and there was a significant relationship between the participants' future preference for behavioural therapies and their concerns about the potential adverse effects of benzodiazepines. A majority of the participants rated general practitioners (GPs) as their first choice and pharmacists as the second choice for discussing behavioural therapies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Specific individual sociodemographic characteristics of benzodiazepine users and their medication\u2010related beliefs influence their current benzodiazepine usage and future intention to trial behavioural therapies as an alternative to their benzodiazepines. Based on the reported preferences of benzodiazepine users in this study, developing and evaluating GP\u2010pharmacist collaborative services to improve the uptake of behavioural therapies as an alternative to benzodiazepines can be recommended.<\/jats:p><\/jats:sec>","DOI":"10.1002\/hsr2.116","type":"journal-article","created":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T05:30:41Z","timestamp":1550813441000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Benzodiazepine usage and patient preference for alternative therapies: A descriptive study"],"prefix":"10.1002","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2628-2320","authenticated-orcid":false,"given":"Fatema\u2010Tun\u2010Naher","family":"Sake","sequence":"first","affiliation":[{"name":"The School of Pharmacy, Faculty of Medicine and Health University of Sydney  Sydney Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Wong","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health The University of Sydney  Sydney Australia"},{"name":"Woolcock Institute of Medical Research The University of Sydney  Sydney Australia"},{"name":"Department of Respiratory and Sleep Medicine Royal Prince Alfred Hospital  Camperdown Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delwyn J.","family":"Bartlett","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health The University of Sydney  Sydney Australia"},{"name":"Woolcock Institute of Medical Research The University of Sydney  Sydney Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bandana","family":"Saini","sequence":"additional","affiliation":[{"name":"The School of Pharmacy, Faculty of Medicine and Health University of Sydney  Sydney Australia"},{"name":"Woolcock Institute of Medical Research The University of Sydney  Sydney Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,2,21]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-012-0148-3"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1192\/apt.bp.110.008631"},{"issue":"1","key":"e_1_2_10_4_1","first-page":"501","article-title":"Benzodiazepines revisited","volume":"5","author":"Mehdi T","year":"2012","journal-title":"Br J Med Pract"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1177\/2042098613486829"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2009.357"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2012.04418.x"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/JGP.0b013e3181a65210"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1532-5415.2002.50254.x"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2012-202374"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3799"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1177\/0004867415616695"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-018-0704-8"},{"key":"e_1_2_10_14_1","unstructured":"The Royal Australian College of General Practitioners.Prescribing drugs of dependence in general practice Part B.2015;http:\/\/www.racgp.org.au\/download\/Documents\/Guidelines\/Addictive\u2010drugs\/Addictive\u2010drugs\u2010guide\u2010B.pdf. Accessed 20th June 2017."},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.11.991"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1159\/000092892"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2296-13-40"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)92535-4"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/gps.930070205"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200624070-00007"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.3109\/13651500903447810"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2014.1763"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201700095"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/imj.12315"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1177\/0004867412466595"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1753-6405.2010.00573.x"},{"issue":"5","key":"e_1_2_10_27_1","first-page":"283","article-title":"Insomnia","volume":"38","author":"Charles J","year":"2009","journal-title":"Aust Fam Physician"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.6616"},{"issue":"2","key":"e_1_2_10_29_1","first-page":"143","article-title":"Prescribing psychotropic medication for elderly patients some physicians' perspectives","volume":"161","author":"Damestoy N","year":"1999","journal-title":"Can Med Assoc J"},{"issue":"1","key":"e_1_2_10_30_1","first-page":"1","article-title":"Insomnia Management in the Australian Primary Care Setting","volume":"17","author":"Sake F\u2010T\u2010N","year":"2017","journal-title":"Behav Sleep Med"},{"issue":"483","key":"e_1_2_10_31_1","first-page":"805","article-title":"Differences in health status between long\u2010term and short\u2010term benzodiazepine users","volume":"52","author":"Zandstra S","year":"2002","journal-title":"Br J Gen Pract"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmh309"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0277-9536(02)00133-8"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1177\/109019817400200403"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/08870449908407311"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-007-0205-5"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.7202\/019627ar"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1037\/0033-2909.124.1.54"},{"issue":"533","key":"e_1_2_10_39_1","first-page":"958","article-title":"Withdrawal from long\u2010term benzodiazepine use: randomised trial in family practice","volume":"56","author":"Vicens C","year":"2006","journal-title":"Br J Gen Pract"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.182.6.498"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp16X683485"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.18549\/PharmPract.2016.03.782"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2017.05.005"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/13.6.491"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2005.07.016"},{"key":"e_1_2_10_46_1","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology.Anatomical Therapeutic Chemical (ATC) Classification System.http:\/\/www.whocc.no\/atc_ddd_index\/. Accessed 16\/11\/2018."},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.5812\/ijem.3505"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocn.13083"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0277-9536(96)00296-1"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00127-011-0344-1"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2017.01.046"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.1177\/2045125317696454"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/0749-5978(91)90020-T"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-69746-3_2"},{"key":"e_1_2_10_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2013.02.016"},{"key":"e_1_2_10_56_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-015-0493-y"},{"key":"e_1_2_10_57_1","first-page":"8","article-title":"Adherence to Long\u2010term therapies and beliefs about medications","volume":"2014","author":"AlHewiti A","year":"2014","journal-title":"Int J Fam Med"},{"key":"e_1_2_10_58_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh587"},{"key":"e_1_2_10_59_1","doi-asserted-by":"publisher","DOI":"10.18773\/austprescr.2015.055"},{"key":"e_1_2_10_60_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1611832"},{"key":"e_1_2_10_61_1","doi-asserted-by":"publisher","DOI":"10.1017\/S2045796016000032"},{"key":"e_1_2_10_62_1","unstructured":"Canadian Agency for Drugs and Technology in Health.Discontinuation strategies for patients with long\u2010term benzodiazepine use: a review of clinical evidence and guidelines.2015;https:\/\/www.cadth.ca\/sites\/default\/files\/rc0682\u2010bzd_discontinuation_strategies_final_0.pdf. Accessed 24\/01\/2019 2019."},{"key":"e_1_2_10_63_1","unstructured":"The Royal Australian College of General Practitioners.Prescribing drugs of dependence in general practice\u2014Part B: Benzodiazepines. Melbourne2015."},{"key":"e_1_2_10_64_1","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp11X593857"},{"key":"e_1_2_10_65_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02364.x"},{"key":"e_1_2_10_66_1","doi-asserted-by":"publisher","DOI":"10.2165\/0023210-200923010-00002"},{"key":"e_1_2_10_67_1","unstructured":"vanHeckeO.Benzodiazepine dependence in primary care. InnovAiT2010."},{"key":"e_1_2_10_68_1","doi-asserted-by":"publisher","DOI":"10.4236\/health.2013.511240"},{"key":"e_1_2_10_69_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.12r07757"},{"key":"e_1_2_10_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brat.2009.06.009"},{"issue":"3","key":"e_1_2_10_71_1","first-page":"431","article-title":"Driving under the influence of benzodiazepines and antidepressants: prescription and abuse","volume":"24","author":"Coutinho D","year":"2011","journal-title":"Acta Med Port"},{"key":"e_1_2_10_72_1","doi-asserted-by":"publisher","DOI":"10.5455\/ejfs.192042"},{"key":"e_1_2_10_73_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0057447"},{"key":"e_1_2_10_74_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.2017.22"},{"key":"e_1_2_10_75_1","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/15.4.302"},{"key":"e_1_2_10_76_1","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/24.4.411"},{"issue":"7","key":"e_1_2_10_77_1","first-page":"992","article-title":"Using cognitive behavioural therapy in practice: qualitative study of family physicians' experiences","volume":"51","author":"Wiebe E","year":"2005","journal-title":"Can Fam Physician"},{"key":"e_1_2_10_78_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-010-1413-2"},{"key":"e_1_2_10_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2017.02.013"},{"key":"e_1_2_10_80_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijpp.12182"},{"key":"e_1_2_10_81_1","doi-asserted-by":"publisher","DOI":"10.1111\/pcn.12232"},{"key":"e_1_2_10_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.12328"},{"key":"e_1_2_10_83_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2014.949"},{"issue":"7386","key":"e_1_2_10_84_1","first-page":"136","article-title":"A novel, pharmacist\u2010led strategy to reduce the prescribing of benzodiazepines in Paisley","volume":"276","author":"Towle I","year":"2006","journal-title":"Pharm J"},{"key":"e_1_2_10_85_1","unstructured":"University of California San Francisco (UCF) Clinical and Translational Science Institute.Sample Size Calculators for Designing Clinical Research.http:\/\/www.sample\u2010size.net\/correlation\u2010sample\u2010size\/. 7.12.18."}],"container-title":["Health Science Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhsr2.116","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hsr2.116","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T13:22:40Z","timestamp":1694352160000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hsr2.116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,21]]},"references-count":84,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["10.1002\/hsr2.116"],"URL":"https:\/\/doi.org\/10.1002\/hsr2.116","archive":["Portico"],"relation":{},"ISSN":["2398-8835","2398-8835"],"issn-type":[{"value":"2398-8835","type":"print"},{"value":"2398-8835","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,21]]},"assertion":[{"value":"2018-09-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e116"}}